Lilly's Tirzepatide Outperforms Semaglutide in Weight Loss Trial Also read: Top selling cancer drugs of 2024 Eli Lilly and Company...

Treatment with tirzepatide in adults with prediabetes and either obesity or overweight conditions has led to substantial weight loss and...

Pfizer Progresses with Once-Daily Oral GLP-1 Receptor Agonist Danuglipron Pfizer has reported positive pharmacokinetic results from...

Boehringer Ingelheim has revealed its strategic plan to propel survodutide, a dual agonist for the glucagon/GLP-1 receptor, into three...

Sanofi has reduced the price of Lantus (insulin glargine injection) 100 Units/mL by 78%, which is Sanofi's most widely prescribed...

May 26, 2022 FDA granted fast track designation for ervogastat/clesacostat for the treatment of NASH Pizer announced that the U.S. Food...